In its first IV case, the FTC sanctioned iV Bars for diseasetreatment claims lacking randomized controlled trial evidence National drug regulators, pharmacy boards, and health agencies play roles in licensing facilities, inspecting cleanrooms, and enforcing compounding standards across different jurisdictions
The Intermountain Health guide emphasizes that: GLP-1s work best when combined with healthy eating, balanced macro-nutrients, and regular movement
The most frequent gastrointestinal side effects include: Nausea (very common: may affect more than 1 in 10 people) Diarrhoea (common: may affect up to 1 in 10 people) Constipation (common: may affect up to 1 in 10 people) Vomiting (common: may affect up to 1 in 10 people) Abdominal pain and discomfort (common) Dyspepsia and bloating (common) These symptoms are typically mild to moderate in severity and often improve over time as the body adjusts to the medication
SUSTAIN-6, conducted in patients with type 2 diabetes, showed a 26% reduction in major adverse cardiovascular events (heart attack, stroke, or cardiovascular death) with semaglutide compared to placebo
